Discovering chronic inflammation biomarkers that define key stages in the Healthy-to-NASH (non-alcoholic steatohepatitis) transition to inform early prevention and treatment strategies

Publications

Seladelpar: New hope for patients with primary biliary cholangitis

Auteurs: Yulia A Nevzorova, Francisco Javier Cubero
Publié dans: Med/ Cell Press, Numéro 5 (5), 2024, ISSN 2666-6359
Éditeur: Science Direct
DOI: 10.1016/j.medj.2024.03.019

Mitochondrial cholesterol: Metabolism and impact on redox biology and disease

Auteurs: Leire Goicoechea,a,b,c Laura Conde de la Rosa,a,b,c Sandra Torres,a,b,c Carmen García-Ruiz,a,b,c,d,∗∗ and José C. Fernández-Checaa,b,c,d,∗
Publié dans: Redox Biology, 2023, ISSN 2213-2317
Éditeur: Elsevier
DOI: 10.1016/j.redox.2023.102643

Dietary and genetic disruption of hepatic methionine metabolism induce acid sphingomyelinase to promote steatohepatitis

Auteurs: Cristina Alarcón-Vila 1, Naroa Insausti-Urkia 1, Sandra Torres 1, Paula Segalés-Rovira 1, Laura Conde de la Rosa 1, Susana Nuñez 1, Raquel Fucho 1, Jose C Fernández-Checa 2, Carmen García-Ruiz 3
Publié dans: Redox Biology, 2023, ISSN 2213-2317
Éditeur: Elsevier BV
DOI: 10.1016/j.redox.2022.102596

aProceedings of the 5th Meeting of Translational Hepatology, organized by the Spanish Association for the Study of the Liver (AEEH)

Auteurs: Alvarado Tapias E, Maya Miles D, Albillos A, Aller R, Ampuero J, Andrade R, Arechederra M, ASpicueta P, Banales, JM, Blas García A, Capparros E, Cardoso Delgado T, Carrillo Vico A, Claria J, Cubero FJ. Díaz Ruíz A, Fernández-Barrena MG, ..., Gahete DM
Publié dans: Gastroenterol Hepatol, 2024, ISSN 2444-3824
Éditeur: Elsevier
DOI: 10.1016/j.gastrohep.2024.502207

Breaking the barriers: the role of gut homeostasis in Metabolic-Associated Steatotic Liver Disease (MASLD)

Auteurs: Raquel Benedé, Francisco Javier Cubero, Yulia A. Nevzorova
Publié dans: Gut microbes, Numéro 1, 2331460, 2024, ISSN 1949-0984
Éditeur: Taylor & Francis
DOI: 10.1080/19490976.2024.2331460

Prior drug allergies are associated with worse outcome in patients with idiosyncratic drug-induced liver injury: A machine learning approach for risk stratification

Auteurs: H. Niu, P. Solis-Muñoz, M. García-Cortés, J. Sanabria-Cabrera, M. Robles-Diaz, R. Romero-Flores, E. Bonilla-Toyos, A. Ortega-Alonso, J. M. Pinazo-Bandera, M. R. Cabello, F. Bessone, N. Hernandez, M. I. Lucena, R. J Andrade, I. Medina-Caliz, I. Álvarez-Álv
Publié dans: Pharmacological Research, Numéro 199, 2024, ISSN 1043-6618
Éditeur: Academic Press
DOI: 10.1016/j.phrs.2023.107030

Advancing with cancer immunotherapeutics: CD29+ regulatory T cell antagonism

Auteurs: Francisco Javier Cubero; Pablo Sarobe; Gisa Tiegs
Publié dans: Gut, Numéro 73, 2023, ISSN 0017-5749
Éditeur: BMJ Journals
DOI: 10.1136/gutjnl-2023-331048

JNKs protect from cholestatic liver disease progression by modulating Apelin signalling

Auteurs: Mohamed, Mohamed Ramadan; Haybaeck, Johannes; Wu, Hanghang; Su, Huan; Bartneck, Matthias; Lin, Cheng; Boekschoten, Mark V.; Boor, Peter; Goeppert, Benjamin; Rupp, Christian; Strnad, Pavel; Davis, Roger J.; Cubero, Francisco Javier; Trautwein, Christian
Publié dans: Crossref, 2023, ISSN 2589-5559
Éditeur: Elsevier
DOI: 10.1016/j.jhepr.2023.100854

Inhibition of ALK3-mediated signalling pathway protects against acetaminophen-induced liver injury

Auteurs: Patricia Marañón 1, Esther Rey 2, Stephania C Isaza 2, Hanghang Wu 3, Patricia Rada 4, Carmen Choya-Foces 2, Antonio Martínez-Ruiz 5, María Ángeles Martín 6, Sonia Ramos 6, Carmelo García-Monzón 2, Francisco Javier Cubero 7, Ángela M Valverde 4, Águeda Go
Publié dans: Redox Biology, 2024, ISSN 2213-2317
Éditeur: Elsevier
DOI: 10.1016/j.redox.2024.103088

Recherche de données OpenAIRE...

Publications

Partager cette page

Télécharger